Avenue Cash And Short Term Investments vs Current Deferred Revenue Analysis
| ATXI Stock | USD 1.90 0.07 3.83% |
Avenue Therapeutics financial indicator trend analysis is way more than just evaluating Avenue Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Avenue Therapeutics is a good investment. Please check the relationship between Avenue Therapeutics Cash And Short Term Investments and its Current Deferred Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avenue Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For more detail on how to invest in Avenue Stock please use our How to Invest in Avenue Therapeutics guide.
Cash And Short Term Investments vs Current Deferred Revenue
Cash And Short Term Investments vs Current Deferred Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Avenue Therapeutics Cash And Short Term Investments account and Current Deferred Revenue. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Avenue Therapeutics' Cash And Short Term Investments and Current Deferred Revenue is 0.49. Overlapping area represents the amount of variation of Cash And Short Term Investments that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of Avenue Therapeutics, assuming nothing else is changed. The correlation between historical values of Avenue Therapeutics' Cash And Short Term Investments and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Short Term Investments of Avenue Therapeutics are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Cash And Short Term Investments i.e., Avenue Therapeutics' Cash And Short Term Investments and Current Deferred Revenue go up and down completely randomly.
Correlation Coefficient | 0.49 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Cash And Short Term Investments
Short Term Investments is an account in the current assets section of Avenue Therapeutics balance sheet. This account contains Avenue Therapeutics investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Avenue Therapeutics fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.Most indicators from Avenue Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Avenue Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avenue Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For more detail on how to invest in Avenue Stock please use our How to Invest in Avenue Therapeutics guide.The Avenue Therapeutics' current Issuance Of Capital Stock is estimated to increase to about 7.9 M, while Selling General Administrative is projected to decrease to under 3.3 M.
Avenue Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Avenue Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Avenue Therapeutics fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 8.9M | 3.2M | 4.0M | 6.8M | 1.9M | 1.8M | |
| Other Current Liab | 1.7M | 714K | 147K | 3.4M | 795K | 1.1M | |
| Total Current Liabilities | 2.1M | 886K | 509K | 3.6M | 1.2M | 2.2M | |
| Total Stockholder Equity | 6.8M | 2.4M | 3.5M | 3.9M | 1.6M | 2.9M | |
| Net Tangible Assets | (631K) | 6.8M | 2.4M | 3.5M | 4.0M | 2.8M | |
| Net Debt | (8.7M) | (3.1M) | (3.8M) | (6.7M) | (1.8M) | (1.9M) | |
| Retained Earnings | (68.1M) | (73.3M) | (77.0M) | (80.6M) | (90.9M) | (86.4M) | |
| Accounts Payable | 368K | 172K | 362K | 150K | 401K | 778.9K | |
| Cash | 8.7M | 3.1M | 3.8M | 6.7M | 1.8M | 1.7M | |
| Cash And Short Term Investments | 8.7M | 3.1M | 3.8M | 6.7M | 1.8M | 1.7M | |
| Common Stock Shares Outstanding | 1.0M | 1.1M | 1.1M | 2.2M | 141.2K | 134.2K | |
| Liabilities And Stockholders Equity | 8.9M | 3.2M | 4.0M | 6.8M | 1.9M | 1.8M | |
| Non Current Liabilities Total | 0.0 | 3.6M | 368K | 172K | 362K | 949.0 | |
| Capital Surpluse | 38.9M | 41.6M | 74.9M | 75.6M | 87.0M | 91.3M | |
| Other Stockholder Equity | 74.9M | 75.6M | 80.4M | 84.5M | 92.5M | 59.9M | |
| Total Liab | 2.1M | 886K | 509K | 3.6M | 1.2M | 1.1M | |
| Total Current Assets | 8.9M | 3.2M | 4.0M | 6.8M | 1.9M | 1.8M | |
| Other Assets | 1.9M | 170K | 113K | 137.0 | 67K | 63.7K | |
| Other Current Assets | 170K | 113K | 107K | 137K | 67K | 129.6K | |
| Net Invested Capital | 6.8M | 2.4M | 3.5M | 3.9M | 1.6M | 1.5M | |
| Net Working Capital | 6.8M | 2.4M | 3.5M | 3.3M | 654K | 621.3K |
Currently Active Assets on Macroaxis
When determining whether Avenue Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Avenue Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Avenue Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Avenue Therapeutics Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avenue Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For more detail on how to invest in Avenue Stock please use our How to Invest in Avenue Therapeutics guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avenue Therapeutics. If investors know Avenue will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avenue Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.76) | Earnings Share 24.78 | Return On Assets (2.01) | Return On Equity (5.35) |
The market value of Avenue Therapeutics is measured differently than its book value, which is the value of Avenue that is recorded on the company's balance sheet. Investors also form their own opinion of Avenue Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Avenue Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avenue Therapeutics' market value can be influenced by many factors that don't directly affect Avenue Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avenue Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avenue Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avenue Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.